Nature Research Round Table: Genome Editing in Human Pluripotent Stem Cells
Dr. Ludovic Vallier from the Wellcome Trust Sanger Institute discusses considerations for genome editing in human pluripotent stem cells (hPSCs). Dr. Vallier is involved at the Cambridge Biomedical Research Center Core Facility, whose services include providing genome-edited iPS cell lines for disease modeling and developing approaches for cell-based therapies. This presentation and the following Q&A session were moderated by Dr. Alex Alderton from the Wellcome Trust Sanger Institute.
This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Note: Some original data from this presentation has been omitted to abide by copyright rules.
EasySep™ 8-Minute Cell Isolation Kits Introduction
Isolate highly purified, untouched immune cells from virtually any sample source or size in as little as 8 minutes, using the EasySep™ column-free cell isolation system, immediately ready for downstream assays
Nature Research Round Table: Genomic Integrity of Human Pluripotent Stem Cells
Dr. Martin Pera from the Jackson Laboratory and International Stem Cell Initiative (ISCI) discusses the biological effects of recurrent genetic variants that arise in human pluripotent stem cells (hPSCs) in culture and during differentiation. This presentation and the following Q&A session were moderated by Dr. Peter Andrews from the University of Sheffield.
This presentation was part of a Round Table series titled “Challenges in Ensuring hPSC Quality”, hosted in partnership with Nature Research. Global experts gathered at the Springer Nature headquarters in London, UK, to tackle some of the most pertinent issues impacting the use of human pluripotent stem cells (hPSCs), ranging from fundamental biology research to therapeutic applications. Explore the full series here.
Note: Some original data from this presentation has been omitted to abide by copyright rules.
Next-Generation Cell Isolation Solutions for T Cell Therapy Research
Join this talk, presented by Dr. Amanda Durkin and Q&A guest Dr. Frann Antignano, to learn about STEMCELL’s cell isolation solutions for fast and easy T cell isolation. This presentation will also focus on large-scale research strategies by introducing our new mobilized leukopaks and feature the Easy 250 EasySep™ Magnet—a scalable and efficient system for manual column-free isolation.
EasySep™小鼠TIL（CD45）正选试剂盒
Nature Research Round Table: Genome Editing in Human Pluripotent Stem Cells Dr. Ludovic Vallier from the Wellcome Trust Sanger Institute discusses considerations for genome editing in human pluripotent stem cells (hPSCs). Dr. Vallier is involved at the Cambridge Biomedical Research Center Core Facility, whose services include providing genome-edited iPS cell lines for disease modeling and developing approaches for cell-based therapies. This presentation and the following Q&A session were moderated by Dr. Alex Alderton from the Wellcome Trust Sanger Institute.
EasySep™ 8-Minute Cell Isolation Kits Introduction Isolate highly purified, untouched immune cells from virtually any sample source or size in as little as 8 minutes, using the EasySep™ column-free cell isolation system, immediately ready for downstream assays
Nature Research Round Table: Genomic Integrity of Human Pluripotent Stem Cells Dr. Martin Pera from the Jackson Laboratory and International Stem Cell Initiative (ISCI) discusses the biological effects of recurrent genetic variants that arise in human pluripotent stem cells (hPSCs) in culture and during differentiation. This presentation and the following Q&A session were moderated by Dr. Peter Andrews from the University of Sheffield.
Next-Generation Cell Isolation Solutions for T Cell Therapy Research Join this talk, presented by Dr. Amanda Durkin and Q&A guest Dr. Frann Antignano, to learn about STEMCELL’s cell isolation solutions for fast and easy T cell isolation. This presentation will also focus on large-scale research strategies by introducing our new mobilized leukopaks and feature the Easy 250 EasySep™ Magnet—a scalable and efficient system for manual column-free isolation.
How to Isolate Cells Directly from Whole Blood Using the EasySep™ Purple/Silver Magnets How to isolate highly purified immune cells directly from whole blood and takes as little as 20 minutes from start to finish
Isolate Highly Purified Cells for HLA Analysis with RosetteSep™ Immunodensity Cell Isolation Learn how RosetteSep™, a rapid cell separation procedure for isolating highly purified cells directly from whole blood, can help increase your sample processing capabilities and provide clear, reliable HLA test results
CAR T Cell Manufacturing Workflow: Isolation, Activation and Expansion Learn about human T cell isolation, activation, and expansion workflow for cell therapy
How EasySep™ Magnetic Cell Separation Technology Works: Fast and Easy Cell Isolation EasySep™ technology, a fast and easy immunomagnetic cell separation technology that allows you to isolate virtually any cell types from a variety of sample sources in as little as 8 minutes
NeuroCult™ Neural Colony-Forming Cell (NCFC) Assay An overview of the NeuroCult™ Neural Colony-Forming Cell (NCFC) Assay
Automate Cell Isolation for Up to 16 Samples with the RoboSep™-16 Cell Separation Instrument Features and benefits of using the fully automated cell isolation platform RoboSep™-16 which allows you to efficiently isolate cells from up to 16 samples simultaneously
